Tagged with A

International Pharmaceutical Manufacturing Gr Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped from 50% to 25%. What have been the main drivers leading to the current scenario? The share of international companies…

Parexel International Italy Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and which opportunities does the local environment provide to the group? The high number of clinical trials conducted in Italy every…

Mersifarma The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect what has been Mersi contribution to the development of the Indonesian pharmaceutical industry? My original vision for the company was…

Bausch & Lomb Germany With a wide experience in other international pharmaceutical companies, what attracted you to come to Bausch&Lomb, the ophthalmology pharma company? Bausch&Lomb offered me a unique set of challenges and possibilities that no other company could thanks to its own transformations and special needs. Since Bausch&Lomb changed ownership in 2007, our…

Lundbeck South Korea What are the origins of Lundbeck in Korea and your involvement in its establishment? I joined Lundbeck just before it was officially established in Korea in April 2002. We started out as a small organization, working through our local partner Whanin. In October that same year we managed to launch…

Neurotech Pharmaceuticals What was the vision behind the creation of Neurotech back in 1998, originally as a Research Center, and then as an independent bio-tech company? It all began in 1998 when special new laws were passed by the Korean government aiming to get professors to contribute to the development of the…

Servier South Korea You have recently been appointed as General Manager of Servier in South Korea, after coming from several years working in Europe. What perception did you have of the far-way Korean pharmaceutical sector before your arrival? I did not have much knowledge of the Korean pharmaceutical industry prior to my arrival,…

GPFarmasi Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the medicines required by the population. What have been the main drivers of this change? The Indonesian pharmaceutical industry started in…

Mensa Group Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the API sector? I was studying pharmaceuticals and my first professional position was also in the pharmaceutical industry. The API business…

Korea Research based Pharmaceutical Industry Since KRPIA’s creation in 1999, what would you say have been its main achievements in the South Korean pharmaceutical landscape? KRPIA’s foremost achievement during its existence has been its contribution to bringing the focus on R&D to the pharmaceutical industry in South Korea. Our member companies spend between 17% and…

Ferring Italy After long experience in the pharmaceutical industry, working in both multinational and local laboratories, you took the reins of the already well-established Italian subsidiary of Ferring a few months ago. To what extent did your previous experiences help you to bring a new perspective to Ferring Italy? My professional path…

IMS Health Italy You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical market? The Italian situation is changing a lot, at a different speed than in other countries. For years, Italians had…